Does TYKERB Cause Malignant neoplasm progression? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Malignant neoplasm progression have been filed in association with TYKERB. This represents 3.4% of all adverse event reports for TYKERB.
18
Reports of Malignant neoplasm progression with TYKERB
3.4%
of all TYKERB reports
2
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TYKERB?
Of the 18 reports, 2 (11.1%) resulted in death, 7 (38.9%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TYKERB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TYKERB Cause?
Diarrhoea (173)
Nausea (63)
Death (47)
Fatigue (44)
Drug ineffective (42)
Rash (37)
Disease progression (29)
Vomiting (29)
Decreased appetite (28)
Palmar-plantar erythrodysaesthesia syndrome (23)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)